We are thrilled to announce our latest press issue, Allergy. In this issue, we explore the dynamic chronic disease of allergies from both an individual and a population-based perspective. (Click here for the full PDF)
First, Dr. Kristy Wolniak defines the term allergy. His piece summarizes the biological interactions involved in allergic reactions and at the same time details what an allergy is. NOT. An infographic accompanies his piece to further illustrate the biological interactions described. This definition sets the stage for the rest of the publication.
Our editorial staff members then highlight a variety of emerging concepts in the research and treatment of allergies.
Personal narratives from individuals living with allergies complete these research-focused blurbs. Although each person’s experience is unique, some underlying themes emerge from these stories. Perhaps in particular, access to life-saving drugs – adrenaline – is critical.
Dr. Ruchi Gupta not only describes his work to understand the epidemiology of childhood food allergies, but also discusses his advocacy work. to ensure that children have access to epinephrine auto-injectors (eg EpiPens) in schools.
Long last, Virginia Nowakowski explores the economic impact of allergies during a discussion with Dr. Lucy Bilaver, expert on allergy-related costs of care.
We hope you enjoy this issue!
– The editorial staff